Log In
BCIQ
Print this Print this
 

Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61)

BCIQ
Print ChartPrint this
0 0 1 2 1 3
Phases of DevelopmentPhase IIIRegistrationMarketed
Cardiovascular

2

1

3

Diagnostic

0

0

1




 Products Targeting Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$27.0M

$13.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today